Veracyte (VCYT) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to -$315.6 million.
- Veracyte's Enterprise Value fell 1513.94% to -$315.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$315.6 million, marking a year-over-year decrease of 1513.94%. This contributed to the annual value of -$239.1 million for FY2024, which is 1045.63% down from last year.
- According to the latest figures from Q3 2025, Veracyte's Enterprise Value is -$315.6 million, which was down 1513.94% from -$219.5 million recorded in Q2 2025.
- In the past 5 years, Veracyte's Enterprise Value registered a high of -$153.4 million during Q2 2022, and its lowest value of -$327.5 million during Q2 2021.
- Over the past 5 years, Veracyte's median Enterprise Value value was -$202.5 million (recorded in 2023), while the average stood at -$215.7 million.
- Per our database at Business Quant, Veracyte's Enterprise Value crashed by 12213.97% in 2021 and then skyrocketed by 5315.24% in 2022.
- Veracyte's Enterprise Value (Quarter) stood at -$173.2 million in 2021, then increased by 10.94% to -$154.2 million in 2022, then tumbled by 40.33% to -$216.5 million in 2023, then fell by 10.46% to -$239.1 million in 2024, then tumbled by 31.99% to -$315.6 million in 2025.
- Its Enterprise Value was -$315.6 million in Q3 2025, compared to -$219.5 million in Q2 2025 and -$186.1 million in Q1 2025.